Compounds that are central nervous system drug candidates for the treatment of cognitive decline and, more particularly, Alzheimers disease are provided. Methods for treatment, inhibition, and/or abatement of cognitive decline and/or Alzheimers disease with a compound or pharmaceutically acceptable salt of the invention are also provided. Also provided are methods of preparing the compounds/compositions of the invention.